TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis
- PMID: 22312126
- PMCID: PMC3732181
- DOI: 10.4049/jimmunol.1102836
TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis
Erratum in
- J Immunol. 2012 Jun 1;188(11):5802
Abstract
TREM2 is an immunoreceptor expressed on osteoclasts (OC) and microglia that transmits intracellular signals through the adaptor DAP12. Individuals with genetic mutations inactivating TREM2 or DAP12 develop the Nasu-Hakola disease (NHD) with cystic-like lesions of the bone and brain demyelination that lead to fractures and presenile dementia. The mechanisms of this disease are poorly understood. In this study, we report that TREM2-deficient mice have an osteopenic phenotype reminiscent of NHD. In vitro, lack of TREM2 impairs proliferation and β-catenin activation in osteoclast precursors (OcP) in response to M-CSF. This defect results in accelerated differentiation of OcP into mature OC. Corroborating the importance of a balanced proliferation and differentiation of OcP for bone homeostasis, we show that conditional deletion of β-catenin in OcP also results in reduced OcP proliferation and accelerated osteoclastogenesis in vitro as well as osteopenia in vivo. These results reveal that TREM2 regulates the rate of osteoclastogenesis and provide a mechanism for the bone pathology in NHD.
Conflict of interest statement
The authors have no financial conflicts of interest.
Figures
Similar articles
-
TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function.J Bone Miner Res. 2006 Feb;21(2):237-45. doi: 10.1359/JBMR.051016. Epub 2005 Oct 20. J Bone Miner Res. 2006. PMID: 16418779
-
DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.J Exp Med. 2003 Aug 18;198(4):669-75. doi: 10.1084/jem.20030027. J Exp Med. 2003. PMID: 12925681 Free PMC article.
-
TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.J Neurosci. 2017 Feb 15;37(7):1772-1784. doi: 10.1523/JNEUROSCI.2459-16.2017. Epub 2017 Jan 11. J Neurosci. 2017. PMID: 28077724 Free PMC article.
-
The enigmatic function of TREM-2 in osteoclastogenesis.Adv Exp Med Biol. 2007;602:97-105. doi: 10.1007/978-0-387-72009-8_13. Adv Exp Med Biol. 2007. PMID: 17966394 Review.
-
Non-pathological roles of microglial TREM2/DAP12: TREM2/DAP12 regulates the physiological functions of microglia from development to aging.Neurochem Int. 2020 Dec;141:104878. doi: 10.1016/j.neuint.2020.104878. Epub 2020 Oct 10. Neurochem Int. 2020. PMID: 33049336 Review.
Cited by
-
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.Gut. 2021 Jul;70(7):1345-1361. doi: 10.1136/gutjnl-2019-319227. Epub 2020 Sep 9. Gut. 2021. PMID: 32907830 Free PMC article.
-
Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice.J Neuroinflammation. 2015 Aug 1;12:139. doi: 10.1186/s12974-015-0366-9. J Neuroinflammation. 2015. PMID: 26232154 Free PMC article.
-
Coordinated transcriptional regulation of bone homeostasis by Ebf1 and Zfp521 in both mesenchymal and hematopoietic lineages.J Exp Med. 2013 May 6;210(5):969-85. doi: 10.1084/jem.20121187. Epub 2013 Apr 8. J Exp Med. 2013. PMID: 23569325 Free PMC article.
-
TREM2 triggers microglial density and age-related neuronal loss.Glia. 2019 Mar;67(3):539-550. doi: 10.1002/glia.23563. Epub 2018 Dec 11. Glia. 2019. PMID: 30548312 Free PMC article.
-
Treatment of Osteoporosis, with a Focus on 2 Monoclonal Antibodies.Med Sci Monit. 2018 Dec 3;24:8758-8766. doi: 10.12659/MSM.912309. Med Sci Monit. 2018. PMID: 30508820 Free PMC article. Review.
References
-
- Leibbrandt A, Penninger JM. RANKL/RANK as key factors for osteoclast development and bone loss in arthropathies. Adv. Exp. Med. Biol. 2009;649:100–113. - PubMed
-
- Barrow AD, Raynal N, Andersen TL, Slatter DA, Bihan D, Pugh N, Cella M, Kim T, Rho J, Negishi-Koga T, Delaisse JM, Takayanagi H, Lorenzo J, Colonna M, Farndale RW, Choi Y, Trowsdale J. OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J. Clin. Invest. 2011;121:3505–3516. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
